Rahul Singhvi - 10 Dec 2024 Form 3 Insider Report for Kairos Pharma, LTD. (KAPA)

Role: Director
Signature: /s/ Rahul Singhvi
Issuer symbol: KAPA
Transactions as of: 10 Dec 2024
Transactions value $: $0
Form type: 3
Date filed: 30 Apr 2025, 16:10
Previous filing: 13 Jun 2024
Next filing: 12 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KAPA	COMMON STOCK						30.1K	10 Dec 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person started serving as an independent director of the board of directors of the Company as of December 10, 2024. On the same date, the Company issued 30,120 restricted stock units ("RSUs") to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 30,120 RSUs are scheduled to vest in one third increments on each of 12/10/2025, 12/10/2026 and 12/10/2027. Accordingly, none of the RSUs have vested as of the date hereof.

Content

The Reporting Person started serving as an independent director of the board of directors of the Company as of December 10, 2024. On the same date, the Company issued 30,120 restricted stock units ("RSUs") to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 30,120 RSUs are scheduled to vest in one third increments on each of 12/10/2025, 12/10/2026 and 12/10/2027. Accordingly, none of the RSUs have vested as of the date hereof.